Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Tissue Studies of Human Eye Diseases
This study is currently recruiting participants.
Verified by National Institutes of Health Clinical Center (CC), December 2008
Sponsored by: National Eye Institute (NEI)
Information provided by: National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier: NCT00001310
  Purpose

The purpose of this study is to better understand the processes involved in the development of various eye conditions, such as uveitis, disorders of the conjunctiva, cornea, vitreous and retina, metabolic or genetic eye diseases or eye tumors, in order to develop better methods of diagnosis and treatment.

Patients who require eye surgery to treat an eye disease or other disease in which the eye is involved may participate in this study. Samples of eye tissue and fluid that are normally removed and discarded during eye surgery will instead be given to researchers for study. The tissues will be examined under microscope and studied using sophisticated chemical and biological tests. Immune cells from blood samples may also be examined. These studies will help better understand and diagnose the various eye diseases and to develop more attractive therapies.


Condition
Conjunctival Disease
Corneal Disease
Eye Disease
Uveitis
Vitreoretinopathy, Proliferative

MedlinePlus related topics: Eye Diseases
U.S. FDA Resources
Study Type: Observational
Official Title: Immunopathology and Molecular Pathology of Ocular Diseases in Humans

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 4000
Study Start Date: March 1992
Detailed Description:

The purpose of this project is to diagnose and evaluate ocular and related tissues with various diseases such as conjunctival, corneal, uveal, vitreoretinal and optic nerve disorders, ocular degenerative, metabolic or genetic diseases and tumors. These will be studied using light microscopy, electron microscopy, confocal microscopy, immunohistochemistry, molecular pathological including polymerase chain reaction and in situ hybridization, as well as measuring the functions of cellular organelles, e.g., mitochondrial function. Lymphocytes in the peripheral blood as well as other involved biopsied tissues and ocular tissue will be compared and categorized by disease. Cytokines, chemokines or growth factors in the blood and ocular fluids will be also analyzed. Elucidating the relationship between the infiltrating cells, ocular resident cells, and their products in various diseases will help us to make diagnoses and increase our understanding of human ocular disorders.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

    1. Participants must be undergoing an eye procedure for clinical care of their condition which requires the removal of tissue specimens or have agreed pre-mortem to donate their eyes after death for research purposes.
    2. Participants must agree to the de-identified storage of their sample for potential use in future research projects.
    3. For conditions where blood is needed for analysis, participants must consent to having blood drawn for research evaluation, and be able to safely give a blood sample.
    4. Participants must be able to give informed consent for themselves and/or their minor children who wish to enroll.

EXCLUSION CRITERIA:

1. Participant is unwilling or unable to give informed consent.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00001310

Contacts
Contact: Patient Recruitment and Public Liaison Office (800) 411-1222 prpl@mail.cc.nih.gov
Contact: TTY 1-866-411-1010

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
  More Information

NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site

Publications:
Study ID Numbers: 920113, 92-EI-0113
Study First Received: November 3, 1999
Last Updated: January 3, 2009
ClinicalTrials.gov Identifier: NCT00001310  
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Ocular Pathology
Ocular Immunology
Clinicopathological Correlation
Immunohistochemical Methods
In Situ Hybridization
Polymerase Chain Reaction
Microdissection
Ocular Disease

Study placed in the following topic categories:
Corneal Diseases
Uveitis
Eye Diseases
Vitreoretinopathy, Proliferative
Retinal Diseases
Conjunctival Diseases

Additional relevant MeSH terms:
Uveal Diseases

ClinicalTrials.gov processed this record on January 15, 2009